PreciGenome is a United States-based startup founded in 2017 that specializes in LifeScience and Microfluidics. Its diverse team is dedicated to leveraging advanced biology and microfluidics technology to revolutionize healthcare and diagnostics. The company's focus lies in developing high-quality microfluidic bio-platforms and solutions, ranging from PCR systems and kits to nanoparticle synthesis systems, single-cell and droplet generators, and the integrated flow iFlow microfluidic controllers. PreciGenome's interdisciplinary team comprises biologists, physicists, chemists, electrical and mechanical engineers, and microfluidic engineers, working together to drive innovation in the Biotechnology and Manufacturing industries. Currently seeking talented individuals to join the team, PreciGenome presents an exciting opportunity for stakeholders in the venture capital space. With a commitment to pioneering advancements in the life sciences, PreciGenome is a promising prospect for potential investors seeking to engage with dynamic and cutting-edge ventures.
There is no investment information
No recent news or press coverage available for PreciGenome.